UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
(Amendment No. )
☒ Filed by the Registrant | | | ☐ Filed by a Party other than the Registrant |
| | Check the appropriate box: | | |||
| | ☐ | | | Preliminary Proxy Statement | |
| | ☐ | | | CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2)) | |
| | ☐ | | | Definitive Proxy Statement | |
| | ☒ | | | Definitive Additional Materials | |
| | ☐ | | | Soliciting Material Under Rule §240.14a-12 | |
| ROYALTY PHARMA PLC |
| (Name of Registrant as Specified In Its Charter) |
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
| | Payment of Filing Fee (Check the appropriate box): | | |||
| | ☒ | | | No fee required. | |
| | ☐ | | | Fee paid previously with preliminary materials. | |
| | ☐ | | | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. | |
